Mather Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-193
| Closed | -$21.3K | – | 1317 |
|
|
2025
Q1 | $21.3K | Hold |
193
| – | – | ﹤0.01% | 1082 |
|
|
2024
Q4 | $26.3K | Hold |
193
| – | – | ﹤0.01% | 1015 |
|
|
2024
Q3 | $22.2K | Sell |
193
-39
| -17% | -$4.49K | ﹤0.01% | 1043 |
|
|
2024
Q2 | $31.9K | Buy |
232
+34
| +17% | +$4.68K | ﹤0.01% | 1130 |
|
|
2024
Q1 | $26K | Buy |
+198
| New | +$26K | ﹤0.01% | 999 |
|